PRAVASTATIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pravastatin, and what generic alternatives are available?
Pravastatin is a drug marketed by Accord Hlthcare, Apnar Pharma Lp, Apotex, Aurobindo Pharma, Biocon Pharma, Chartwell Rx, Cipla, Dr Reddys Labs Inc, Glenmark Pharms Ltd, Hisun Pharm Hangzhou, Norvium Bioscience, Pliva Hrvatska Doo, Ranbaxy Labs Ltd, Teva, Teva Pharms, Watson Labs, and Zydus Pharms Usa. and is included in eighteen NDAs.
The generic ingredient in PRAVASTATIN is pravastatin sodium. There are sixteen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the pravastatin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pravastatin
A generic version of PRAVASTATIN was approved as pravastatin sodium by TEVA on April 24th, 2006.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PRAVASTATIN?
- What are the global sales for PRAVASTATIN?
- What is Average Wholesale Price for PRAVASTATIN?
Summary for PRAVASTATIN
| US Patents: | 0 |
| Applicants: | 17 |
| NDAs: | 18 |
| Drug Prices: | Drug price information for PRAVASTATIN |
| Drug Sales Revenues: | Drug sales revenues for PRAVASTATIN |
| DailyMed Link: | PRAVASTATIN at DailyMed |
See drug prices for PRAVASTATIN
US Patents and Regulatory Information for PRAVASTATIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 079187-001 | May 27, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Dr Reddys Labs Inc | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076714-004 | Dec 28, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pliva Hrvatska Doo | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 077730-002 | Nov 21, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
